S&P Futures
4,293.50 -4.75 (-0.11%) Dow Futures
33,867.00 -6.00 (-0.02%) Nasdaq Futures
13,663.25 -18.00 (-0.13%) Russell 2000 Futures
2,022.80 -1.00 (-0.05%) Crude Oil
88.74 -0.67 (-0.75%) Gold
1,795.70 -2.40 (-0.13%)
NanoVibronix, Inc. (NAOV)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.6873 |
| Open | 0.7300 |
| Bid | 0.0000 x 1000 |
| Ask | 0.0000 x 800 |
| Day's Range | 0.6800 - 0.7300 |
| 52 Week Range | 0.4810 - 4.1900 |
| Volume | |
| Avg. Volume | 114,091 |
| Market Cap | 20.296M |
| Beta (5Y Monthly) | 0.63 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4020 |
| Earnings Date | Aug 16, 2022 - Aug 20, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for NAOV
Related Research
- NanoVibronix, Inc.Mid Cap U.S. Pick List August 2022This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.RatingFair ValueEconomic Moat5 days agoMorningstar
- Simply Wall St.
Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Business Wire
NanoVibronix Announces Webinar Series to Promote UroShield
ELMSFORD, N.Y., July 12, 2022--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced its Australian distributor, DukeHill HC, is launching a series of educational webinars to present the Company’s UroShield technology to clinicians. The series, which will feature clinicians and patients’ experiences, seeks to inform clinicians about the use, benefits and outcomes achieved
- Business Wire
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
ELMSFORD, N.Y., June 29, 2022--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it is shifting the majority of its manufacturing operations to Singapore in order to allow scalability increase efficiency and address potential supply chain delays.
